Pfizer and ChemRar High Tech Center Announce Plans to Explore Innovative Medical Research and Development Partnership in Russia

Pfizer and the Russian pharmaceutical investment and R&D group ChemRar High Tech Center announced that they have signed a memorandum of understanding to explore a collaboration focused on research, development and commercialization of innovative drugs in Russia and other countries.
Bradenton Herald